Clinical Trials in Philadelphia

Showing 12221-12240 of 20,904 trials

A Study to Evaluate the Pharmacodynamic Activity of E2082 in Adult Participants With Photosensitive Epilepsy

NCT03686033

The primary purpose of the study is to assess pharmacodynamic (PD) activity of E2082 as measured by suppression of epileptic photoparoxysmal response (PPR) in the participant's most sensitive eye condition in participants with photosensitive epilepsy, compared to placebo.

Photosensitive Epilepsy

Eisai Inc.8 participantsStarted Oct 2018

Little Rock, Arkansas, United States • Boise, Idaho, United States • Baltimore, Maryland, United States +2 more locations

RECRUITING< 1 mile

Spinal Cord Injury Registry - North American Clinical Trials Network

NCT00178724

The NACTN Spinal Cord Injury Registry is a network of clinical centers collecting de-identified data from patients admitted through the Emergency Department of a NACTN center at the time of injury with an initial (first time) spinal cord injury (SCI). Information will be collected on the natural history of SCI and course of treatment through the first 12 months from the date of injury or long as medically indicated. Data collected includes imaging information from CT or MRI scans, neurological and general medical outcome and rehabilitation evaluation. No intervention is given other than standard of care for spinal cord injury, intensive monitoring and frequent follow up care.

Spinal Cord Injury

Robert G. Grossman, MD1,500 participantsStarted Jul 2005

Miami, Florida, United States • Louisville, Kentucky, United States • New Orleans, Louisiana, United States +11 more locations

A Study to Evaluate the Pharmacodynamic Activity of E2082 in Adult Participants With Photosensitive Epilepsy

Spinal Cord Injury Registry - North American Clinical Trials Network

Find Trials by Condition in Philadelphia

Multi-Center Study of Iron Overload: Survey Study (MCSIO)

Analysis of 18F-AV-1451 PET Imaging in Cognitively Healthy, MCI, and AD Subjects

EVOLVE Short DAPT Study

Study of Rhopressa® for the Reduction of Elevated Intraocular Pressure in Patients With Glaucoma or Ocular Hypertension in a Real-world Setting

Loteprednol Etabonate Ophthalmic Gel for the Treatment of Ocular Inflammation and Pain Following Cataract Surgery

Pacritinib Versus Best Available Therapy to Treat Myelofibrosis

A Open-label Study to Evaluate the Safety of TRV130 in Patients With Acute Pain

A Study of Faricimab (RO6867461) in Participants With Center-Involving Diabetic Macular Edema

A Study of ARRY-520 and Bortezomib Plus Dexamethasone in Patients With Relapsed/Refractory Multiple Myeloma

AVN944 in Combination With Gemcitabine for the Treatment of Pancreatic Cancer

PTX-200, Paclitaxel, Doxorubicin Hydrochloride, and Cyclophosphamide in Treating Patients With Stage IIB-IV Breast Cancer

Evaluation of Exufiber Ag+ and Other Gelling Fibre Dressings

Study Evaluating ERB-041 With Methotrexate in Rheumatoid Arthritis

A Study to Assess Resistance and Durability of Response to ABT-493 and/or ABT-530

A Study of GDC-0853 in Participants With Refractory Chronic Spontaneous Urticaria (CSU).

Intravenous BI 836826 in Combination With Ibrutinib in Relapsed/Refractory CLL Patients Who Have Been Pre-treated With at Least One Prior Line of Systemic Therapy, and Who Are Eligible for Treatment With Ibrutinib

A Study of BYL719 in Adult Patients With Advanced Solid Malignancies, Whose Tumors Have an Alteration of the PIK3CA Gene

Extension Study to Assess Safety and Efficacy of AIN457 in Patients With Active Non-infectious Uveitis